Department of Molecular Genetics of Intracellular Transport, Institute of Gene Biology, Russian Academy of Sciences, 34/5, Vavilov St., 119334, Moscow, Russia.
J Control Release. 2012 Oct 28;163(2):211-9. doi: 10.1016/j.jconrel.2012.08.027. Epub 2012 Sep 1.
We have synthesized and investigated properties of new PEI-PEG-based polyplexes containing MC1SP-peptide, a ligand specific for melanocortin receptor-1 (targeted polyplexes), and control polyplexes without this ligand peptide (non-targeted polyplexes). The targeted polyplexes demonstrated receptor-mediated transfection of Cloudman S91 (clone M-3) murine melanoma cells that was more efficient than with the non-targeted ones. Transfection with the targeted polyplexes was inhibited by chlorpromazine, an inhibitor of the clathrin-mediated endocytosis pathway, and, to a lesser extent, by filipin III or nystatin, inhibitors of the lipid-raft endocytosis pathway, whereas transfection with the non-targeted polyplexes was inhibited mainly by nystatin or filipin III. The targeted polyplexes caused significantly higher in vivo transfection of melanoma tumor cells after intratumoral administration compared to the non-targeted control. The targeted polyplexes carrying the HSVtk gene, after ganciclovir administration, more efficiently inhibited melanoma tumor growth and prolonged the lifespan of DBA/2 tumor-bearing mice compared to the non-targeted ones. Packed targeted polyplexes appeared and accumulated in the melanoma cells 6h earlier than the non-targeted ones. The targeted polyplexes enter into the nuclei of the melanoma cells more rapidly than the non-targeted control, and this difference may also be attributed to processes of receptor-mediated endocytosis. We believe that these data may be useful for the optimization of polyplex systems.
我们合成并研究了含有 MC1SP-肽的新型 PEI-PEG 基聚合物的性质,MC1SP-肽是一种针对黑素皮质素受体-1(靶向聚合物)的配体,以及不含该配体肽的对照聚合物(非靶向聚合物)。靶向聚合物显示出对 Cloudman S91(克隆 M-3)鼠黑色素瘤细胞的受体介导转染,其效率高于非靶向聚合物。用氯丙嗪(一种网格蛋白介导的内吞作用途径的抑制剂)和小菌素 III 或制霉菌素(脂质筏内吞作用途径的抑制剂)抑制靶向聚合物的转染,而用非靶向聚合物的转染主要被制霉菌素或小菌素 III 抑制。与非靶向对照相比,经肿瘤内给药后,靶向聚合物在体内更有效地转染黑色素瘤肿瘤细胞。携带 HSVtk 基因的靶向聚合物在给予更昔洛韦后,与非靶向聚合物相比,更有效地抑制黑色素瘤肿瘤生长并延长 DBA/2 荷瘤小鼠的寿命。与非靶向聚合物相比,靶向聚合物在黑色素瘤细胞中更早地出现并积累 6 小时。靶向聚合物比非靶向对照更快地进入黑色素瘤细胞核,这种差异也可能归因于受体介导的内吞作用过程。我们相信这些数据可能有助于优化聚合物系统。